pirfenidone has been researched along with hyaluronoglucosaminidase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didiasova, M; Gungl, A; Klepetko, W; Kosanovic, D; Kreuter, M; Kwapiszewska, G; Marsh, LM; Olschewski, A; Olschewski, H; Schaefer, L; Schermuly, RT; Schneider, M; Seeger, W; Sinn, K; Thekkekara Puthenparampil, H; Weiss, B; Wilhelm, J; Wujak, L; Wygrecka, M | 1 |
| Cai, M; Chen, J; Chen, Y; Guo, Y; Huang, J; Huang, W; Lai, M; Liang, L; Lin, L; Liu, M; Xie, L; Zhang, X; Zhang, Y; Zhu, K | 1 |
2 other study(ies) available for pirfenidone and hyaluronoglucosaminidase
| Article | Year |
|---|---|
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Cell Movement; Cell Proliferation; Down-Regulation; Extracellular Matrix; Female; Fibroblasts; Gene Expression Profiling; Gene Ontology; Humans; Hyaluronoglucosaminidase; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Proteins; Pyridones; Transcriptome | 2018 |
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Hyaluronoglucosaminidase; Liver Neoplasms; Lung Neoplasms; Signal Transduction; Sorafenib; Tumor Microenvironment | 2023 |